Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro

被引:252
作者
Lyu, SY
Rhim, JY
Park, WB
机构
[1] Seoul Womens Univ, Coll Nat Sci, Seoul 139774, South Korea
[2] Univ Nottingham, Sch Pharm, Immune Modulat Res Grp, Nottingham NG7 2RD, England
关键词
flavonoids; herpes simplex virus (HSV); cytopathic effect (CPE)-inhibitory assay; selectivity index (SI); plaque reduction assay; yield reduction assay; Vero cells;
D O I
10.1007/BF02978215
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Flavonoids, a group of low molecular weight phenylbenzopyrones, have various pharmacological properties including antioxidant, anticancer, bactericidal, and anti-inflammatory. We carried out anti-herpetic assays on 18 flavonoids in five classes and a virus-induced cytopathic effect (CPE) inhibitory assay, plaque reduction assay, and yield reduction assay were performed. When flavonoids were applied at various concentrations to Vero cells infected by HSV-1 and 2, most of the flavonoids showed inhibitory effects on virus-induced CPE. Among the flavonoids, EC, ECG (flavanols), genistein (isoflavone), naringenin (flavanone), and quercetin (flavonol) showed a high level of CPE inhibitory activity. The antiviral activity of flavonoids were also examined by a plaque reduction assay. EC, ECG, galangin, and kaempferol showed a strong antiviral activity, and catechin, EGC, EGCG, naringenin, chrysin, baicalin, fisetin, myricetin, quercetin, and genistein showed moderate inhibitory effects against HSV-1. In these experiments, flavanols and flavonols appeared to be more active than flavones. Furthermore, treatment of Vero cells with ECG and galangin (which previously showed strong antiviral activities) before virus adsorption led to a slight enhancement of inhibition as determined by a yield reduction assay, indicating that an intracellular effect may also be involved.
引用
收藏
页码:1293 / 1301
页数:9
相关论文
共 28 条
[1]   Cytotoxic effect (on tumor cells) and in vitro antiviral activity against herpes simplex virus of synthetic spongiane diterpenes [J].
Betancur-Galvis, L ;
Zuluaga, C ;
Arnó, M ;
González, MA ;
Zaragozá, RJ .
JOURNAL OF NATURAL PRODUCTS, 2002, 65 (02) :189-192
[2]   Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection [J].
Bourne, N ;
Stanberry, LR ;
Kern, ER ;
Holan, G ;
Matthews, B ;
Bernstein, DI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2471-2474
[3]   THE ANTIVIRAL ACTIVITY AGAINST HERPES-SIMPLEX VIRUS OF THE TRITERPENOID COMPOUNDS CARBENOXOLONE SODIUM AND CICLOXOLONE SODIUM [J].
DARGAN, DJ ;
SUBAKSHARPE, JH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :185-200
[4]   CELL-LINES CONTAINING VARICELLA-ZOSTER VIRUS OPEN READING FRAME-62 AND EXPRESSING THE IE-175 PROTEIN COMPLEMENT ICP4 MUTANTS OF HERPES-SIMPLEX VIRUS TYPE-1 [J].
FELSER, JM ;
KINCHINGTON, PR ;
INCHAUSPE, G ;
STRAUS, SE ;
OSTROVE, JM .
JOURNAL OF VIROLOGY, 1988, 62 (06) :2076-2082
[5]  
Freshney R.I., 1994, CULTURE ANIMAL CELLS, P331
[6]   ACTIVATION OF HUMAN PAPILLOMAVIRUS TYPE-18 GENE-EXPRESSION BY HERPES-SIMPLEX VIRUS TYPE-1 VIRAL TRANSACTIVATORS AND A PHORBOL ESTER [J].
GIUS, D ;
LAIMINS, LA .
JOURNAL OF VIROLOGY, 1989, 63 (02) :555-563
[7]  
HARBORNE JB, 1994, ADV RES 1986, P441
[8]   The biochemistry and medical significance of the flavonoids [J].
Havsteen, BH .
PHARMACOLOGY & THERAPEUTICS, 2002, 96 (2-3) :67-202
[9]   HERPES-SIMPLEX VIRUS-INFECTION AS A RISK FACTOR FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN HETEROSEXUALS [J].
HOOK, EW ;
CANNON, RO ;
NAHMIAS, AJ ;
LEE, FF ;
CAMPBELL, CH ;
GLASSER, D ;
QUINN, TC .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (02) :251-255
[10]  
Hudson JB, 1990, ANTIVIRAL COMPOUNDS, P119